Article ; Online: Prescription drugs and mitochondrial metabolism.
2022 Volume 42, Issue 4
Abstract: Mitochondria are central to the physiology and survival of nearly all eukaryotic cells and house diverse metabolic processes including oxidative phosphorylation, reactive oxygen species buffering, metabolite synthesis/exchange, and Ca2+ sequestration. ... ...
| Abstract | Mitochondria are central to the physiology and survival of nearly all eukaryotic cells and house diverse metabolic processes including oxidative phosphorylation, reactive oxygen species buffering, metabolite synthesis/exchange, and Ca2+ sequestration. Mitochondria are phenotypically heterogeneous and this variation is essential to the complexity of physiological function among cells, tissues, and organ systems. As a consequence of mitochondrial integration with so many physiological processes, small molecules that modulate mitochondrial metabolism induce complex systemic effects. In the case of many commonly prescribed drugs, these interactions may contribute to drug therapeutic mechanisms, induce adverse drug reactions, or both. The purpose of this article is to review historical and recent advances in the understanding of the effects of prescription drugs on mitochondrial metabolism. Specific 'modes' of xenobiotic-mitochondria interactions are discussed to provide a set of qualitative models that aid in conceptualizing how the mitochondrial energy transduction system may be affected. Findings of recent in vitro high-throughput screening studies are reviewed, and a few candidate drug classes are chosen for additional brief discussion (i.e. antihyperglycemics, antidepressants, antibiotics, and antihyperlipidemics). Finally, recent improvements in pharmacokinetics models that aid in quantifying systemic effects of drug-mitochondria interactions are briefly considered. |
|---|---|
| MeSH term(s) | Energy Metabolism ; Mitochondria/metabolism ; Oxidative Phosphorylation ; Prescription Drugs/metabolism ; Prescription Drugs/pharmacology ; Reactive Oxygen Species/metabolism |
| Chemical Substances | Prescription Drugs ; Reactive Oxygen Species |
| Language | English |
| Publishing date | 2022-03-22 |
| Publishing country | England |
| Document type | Journal Article ; Review |
| ZDB-ID | 764946-0 |
| ISSN | 1573-4935 ; 0144-8463 |
| ISSN (online) | 1573-4935 |
| ISSN | 0144-8463 |
| DOI | 10.1042/BSR20211813 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 1676: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.